Pharmacists in Sw Ranches, FL Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Dr. Vineet Talwar, PHARM.D Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 15801 Sheridan St, Sw Ranches, FL 33331 Phone: 954-442-6875 |
Mr. Sony Joseph Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4901 Volunteer Rd, Sw Ranches, FL 33330 Phone: 954-680-2300 Fax: 954-680-2608 |
Mr. Dang Lan Bach Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6700 Dykes Rd, Sw Ranches, FL 33331 Phone: 954-434-9956 Fax: 954-434-9962 |
 Julie C Shterenvaser, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6451 Appaloosa Trl, Sw Ranches, FL 33330 Phone: 954-483-8126 |
News Archive
Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers
Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham.
Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma
Genentech, a member of the Roche Group, today announced that the company submitted a New Drug Application for vemurafenib to the U.S. Food and Drug Administration for people with BRAF V600 mutation-positive metastatic melanoma, and that Roche submitted a Marketing Authorization Application to the European Medicines Agency for vemurafenib in the same indication.
New microfluidic device offers insights on cancer metastasis
As cancer grows, it evolves. Individual cells become more aggressive and break away to flow through the body and spread to distant areas.
Two new studies offer clearer picture of rise of hepatocellular carcinoma
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Proceedings offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 percent five-year survival rate when detected in later stages.
› Verified 4 days ago